Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Precision Medicine in Oncology^®

Breast Cancer

Gastrointestinal Cancer

Precision Medicine in Oncology^®

FDA Grants Pembrolizumab Priority Review for TMB-High Tumors

The FDA has granted a priority review designation to pembrolizumab for the treatment of patients with unresectable or metastatic solid tumors with tissue tumor mutational burden-high status.
Read More >>

ctDNA Provides Prognostic and Predictive Value in Early-Stage Breast Cancer

New Era of CDK Targeting Gets Rolling in Oncology

Immunotherapy Biomarker Testing Depends on Tumor Type

Expert Discusses Tissue Versus Liquid Biopsy in Next-Generation Sequencing in Lung Cancer

Pennell Shares Best Practices for Molecular Testing in Lung Cancer

View More Stories >>

View Conference Coverage

2020 SGO Annual Meeting

2020 School of Gastrointestinal Oncology

2020 New York GU

2020 Miami Breast Cancer Conference

2020 HCC-TAG Conference

Dr. Otterson on When to Start Immunotherapy in NSCLC

Dr. Levy on Emerging Biomarkers and Corresponding Therapies in Lung Cancer

Dr. Hamid on the Evolution of Precision Medicine in Prostate Cancer

Dr. Husain on Ongoing Research Evaluating Plasma-Based Testing in Lung Cancer

Dr. Goldman on the Use of Immunotherapy in Oncogene-Driven NSCLC

Dr. Iyer on Investigational FGFR Inhibitors in Metastatic Urothelial Carcinoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Combining Targeted Therapies in CLL

Hepatocellular Carcinoma: Antiangiogenic Therapy Options

Targeted Therapy for KRAS-Mutant NSCLC

Treatment of Germline BRCA with PARP and Checkpoint

OncLive houses thousands of videos that provide updates and information.
See more Videos

Emerging Agents for HER2+ mBC: Targeted Therapeutics

Evolving Landscape of HER2-Targeted Therapy in Breast Cancer

TRK Inhibition: Future Challenges and Evolutions

Use of TRK Inhibition in Specific Tumor Types

The Importance and Evolution of NGS Testing

Envisioning Use of TRK Inhibitors in Clinical Practice

TRK Inhibition in CNS Tumors or Metastases

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Program

Treatment of Advanced Head & Neck Squamous Cell Carcinoma

Ezra Cohen, MD; Robert Ferris, MD, PhD, FACS; and Jared Weiss, MD, provide a comprehensive overview of diagnosis and treatment of advanced head and neck squamous cell carcinoma (HNSCC), including multidisciplinary care and emerging evidence surrounding novel therapies. Treatment approaches to HPV-positive and HPV-negative tumors are explored.